Clinical Trial Update: Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of nintedanib plus bevacizumab in advanced solid tumors has completed, assessing safety and preliminary activity across several cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Nintedanib (nintedanib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Renal Cell Carcinoma, Colorectal Adenocarcinoma | Phase 1 | Status: COMPLETED